STOCK TITAN
  1. Home
  2. Sec-filings
  3. ANGO
  4. [Form 4] ANGIODYNAMICS INC Insider Trading Activity

AngioDynamics (ANGO) SVP covers tax obligations through share withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AngioDynamics Inc. reports that SVP Quality and Regulatory Warren Nighan Jr. had a total of 3,777 common shares withheld in three exempt dispositions on July 16, 17 and 20, 2026, at prices from $13.51 to $14.14 per share to satisfy tax withholding obligations tied to pre-determined vesting of previously granted restricted stock units. These events were not designated as occurring under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Nighan Warren JR
Role SVP Quality and Regulatory
Type Security Shares Price Value
Tax Withholding Common Stock F3 251 $13.71 $3K
Tax Withholding Common Stock F2 1,373 $13.51 $19K
Tax Withholding Common Stock F1 2,153 $14.14 $30K
Holdings After Transaction: Common Stock — 66,126 shares (Direct)
Footnotes (3)
  1. F1. The exempt disposition of 2,153 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
  2. F2. The exempt disposition of 1,373 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
  3. F3. The exempt disposition of 251 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Shares withheld for taxes on 2026-07-16 2153.0000 shares Exempt disposition of common stock to satisfy tax withholding on RSUs granted July 16, 2025
Shares withheld for taxes on 2026-07-17 1373.0000 shares Exempt disposition of common stock to satisfy tax withholding on RSUs granted July 17, 2024
Shares withheld for taxes on 2026-07-20 251.0000 shares Exempt disposition of common stock to satisfy tax withholding on RSUs granted July 20, 2022
Total shares for tax liabilities 3777 shares Aggregate common shares delivered/withheld for tax obligations across three July 2026 transactions
Price per share on 2026-07-16 14.1400 USD Per-share price used for tax-withholding disposition of 2,153 common shares
Price per share on 2026-07-17 13.5100 USD Per-share price used for tax-withholding disposition of 1,373 common shares
exempt disposition regulatory
"The exempt disposition of 2,153 shares of common stock of AngioDynamics, Inc."
restricted stock units financial
"vesting of shares underlying restricted stock units granted to the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"was made to satisfy tax withholding obligations in connection with the pre-determined vesting"
pre-determined vesting financial
"in connection with the pre-determined vesting of shares underlying restricted stock units"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider activity did AngioDynamics (ANGO) report for Warren Nighan Jr.?
AngioDynamics reported that SVP Warren Nighan Jr. had 3,777 common shares withheld in three exempt dispositions on July 16, 17 and 20, 2026. The shares covered tax withholding obligations related to vesting restricted stock units, not open-market sales.

Were the AngioDynamics (ANGO) insider transactions open-market sales?
No. All three transactions were reported as exempt dispositions coded "F" to satisfy tax withholding obligations on vesting restricted stock units. They reflect shares delivered or withheld for taxes, rather than discretionary open-market sales by the executive.

How many AngioDynamics (ANGO) shares were used for tax withholding on July 16, 2026?
On July 16, 2026, 2,153 shares of AngioDynamics common stock were disposed of at $14.1400 per share. Footnotes state this satisfied tax withholding for the pre-determined vesting of restricted stock units granted on July 16, 2025.

What RSU grants were involved in the recent AngioDynamics (ANGO) tax withholdings?
The withheld shares related to vesting of restricted stock units granted on July 16, 2025, July 17, 2024, and July 20, 2022. For each grant, a portion of AngioDynamics common shares was disposed of to cover tax obligations at vesting.

Were AngioDynamics (ANGO) insider tax-withholding transactions under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the footnotes describe the trades as exempt dispositions for tax withholding. They are reported as mechanical tax events, not as transactions under a Rule 10b5-1 trading plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nighan Warren JR
(Last)(First)(Middle)
ANGIODYNAMICS, INC.
14 PLAZA DRIVE
(Street)
LATHAM NEW YORK 12110
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ ANGO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP Quality and Regulatory
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/16/2026F2,153(1)D$14.1467,750D
Common Stock07/17/2026F1,373(2)D$13.5166,377D
Common Stock07/20/2026F251(3)D$13.7166,126D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The exempt disposition of 2,153 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
2. The exempt disposition of 1,373 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
3. The exempt disposition of 251 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
/s/ Lawrence T. Weiss, Attorney in Fact07/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR